pharmaphorum.com, and its digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate
London, England
- Tweets 70,899
- Following 2,932
- Followers 24,063
- Likes 4,496
Pinned Tweet
In order to better serve our audience, we're shifting our social media focus to other platforms.
Find us on LinkedIn, BlueSky, and YouTube for more pharma news and analysis, or click here: pharmaphorum.com/register to subscribe to our email newsletter.
1,373
Deep Dive: How past #vaccines discoveries shaped today’s healthcare landscape. Check out the full feature here: pharmaphorum.com/deep-dive/h… #MedicalResearch #PharmaInsights
1
3
1,059
In 2025, as #biopharma companies embrace #AI-first, purpose-built solution #strategies to better serve #healthcareprofessionals and #patients.
pharmaphorum.com/digital/sma…
2
832
If you missed, it take a look back at the final edition of #ChangingFaces for #2024.
pharmaphorum.com/rd/changing…
2
750
The promise of #AI in #biopharma is equally tempered by the long journey ahead and the technology’s many uncertainties.
pharmaphorum.com/digital/bio…
1
648
The misuse of #prescriptionmedications like #Wegovy and #Ozempic, compounded by a lack of stringent clinical procedures, underscores the urgent need for heightened accountability.
pharmaphorum.com/patients/ta…
1
561
With the growing demand for #chronicdisease treatments and the #ageing baby boomer population, the #infusionmarket is set for significant growth.
pharmaphorum.com/patients/fo…
2
420
If you missed, it take a look back at the final edition of #ChangingFaces for #2024.
pharmaphorum.com/rd/changing…
332
Why is rare disease treatment so challenging? And how can cell & gene therapies help? Join @IPGHealth for a webinar on 5th March to find out.
Register here: bit.ly/3Cpx0hC
#raredisease #ppwebinar
ALT Exploring the future: opportunities and challenges in cell and gene therapy for rare disease
248
In 2025, as #biopharma companies embrace #AI-first, purpose-built solution #strategies to better serve #healthcareprofessionals and #patients.
pharmaphorum.com/digital/sma…
208
Just as #HCPs tailor their approach and #communication to meet the unique needs of each #patient, #healthcare and #pharmabrands need to recognise and address the individual needs and preferences of providers themselves.
pharmaphorum.com/patients/ca…
180
With the growing demand for #chronicdisease treatments and the #ageing baby boomer population, the #infusionmarket is set for significant growth.
pharmaphorum.com/patients/fo…
1
198
The promise of #AI in #biopharma is equally tempered by the long journey ahead and the technology’s many uncertainties.
pharmaphorum.com/digital/bio…
1
252
In 2025, as #biopharma companies embrace #AI-first, purpose-built solution #strategies to better serve #healthcareprofessionals and #patients.
pharmaphorum.com/digital/sma…
1
320
If you missed, it take a look back at the final edition of #ChangingFaces for #2024.
pharmaphorum.com/rd/changing…
1
1
384
The misuse of #prescriptionmedications like #Wegovy and #Ozempic, compounded by a lack of stringent clinical procedures, underscores the urgent need for heightened accountability.
pharmaphorum.com/patients/ta…
1
1
409
Just as #HCPs tailor their approach and #communication to meet the unique needs of each #patient, #healthcare and #pharmabrands need to recognise and address the individual needs and preferences of providers themselves.
pharmaphorum.com/patients/ca…
1
239
The misuse of #prescriptionmedications like #Wegovy and #Ozempic, compounded by a lack of stringent clinical procedures, underscores the urgent need for heightened accountability.
pharmaphorum.com/patients/ta…
1
1
225
With the growing demand for #chronicdisease treatments and the #ageing baby boomer population, the #infusionmarket is set for significant growth.
pharmaphorum.com/patients/fo…
1
187
Just as #HCPs tailor their approach and #communication to meet the unique needs of each #patient, #healthcare and #pharmabrands need to recognise and address the individual needs and preferences of providers themselves.
pharmaphorum.com/patients/ca…
1
173